Skip to main content

21 APRIL, 2011

bioMérieux - First Quarter 2011 Business Review

Marcy L'Etoile, France - April 21, 2011. Sales growth: 3.5% like-for-like

  • Strong momentum in North America
  • Temporary slowdown in China and India
  • Robust growth in clinical microbiology

2011 sales growth objective confirmed at 5% to 6%

bioMérieux, a world leader in the field of in vitro diagnostics, today released its business review for the three months ended March 31, 2011.
Net sales for the period reached €328 million, up a reported 6.8% from €307 million in first-quarter 2010. Growth amounted to 3.5% like-for-like (at constant exchange rates and scope of consolidation).

Download

Filename
biomerieux_pr_sales_q1_2011_en.pdf
Size
58 KB
Format
application/pdf